Sarepta Therapeutics, Inc.

LSE:0L35 Stock Report

Market Cap: US$12.2b

Sarepta Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

LSE:0L35 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Mar 24SellUS$93,550Kathryn BoorIndividual761US$122.93
05 Mar 24SellUS$385,480Stephen MayoIndividual3,135US$122.96
01 Mar 24SellUS$153,960Ian EstepanIndividual1,200US$128.30
01 Mar 24SellUS$257,676Bilal ArifIndividual2,000US$129.71
01 Mar 24SellUS$250,680Ryan BrownIndividual2,000US$125.34
03 Nov 23BuyUS$2,001,800Douglas IngramIndividual25,225US$81.26
03 Nov 23BuyUS$3,940,500Richard BarryIndividual50,000US$78.81
14 Aug 23BuyUS$1,092,429Michael ChambersIndividual9,979US$109.89
11 Aug 23BuyUS$2,559,272Michael ChambersIndividual23,686US$108.05
10 Aug 23BuyUS$3,701,067Michael ChambersIndividual34,867US$106.26

Insider Trading Volume

Insider Buying: 0L35 insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of 0L35?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7390.000782%
State or Government39,6770.042%
Individual Insiders4,209,2494.45%
General Public6,706,1337.1%
Institutions83,549,81088.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 64.19% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.33%
The Vanguard Group, Inc.
8,816,124US$1.1b2.84%0.02%
6.57%
BlackRock, Inc.
6,211,792US$799.9m2.95%0.01%
5.66%
Janus Henderson Group plc
5,345,785US$688.4m-7.55%0.3%
5.02%
Capital Research and Management Company
4,741,485US$610.6m99.1%0.03%
4.6%
Avoro Capital Advisors LLC
4,344,444US$559.4m7.94%8.23%
4.37%
Wellington Management Group LLP
4,127,610US$531.5m5.57%0.08%
3.36%
Richard Barry
3,178,319US$409.3m3.25%no data
2.81%
T. Rowe Price Group, Inc.
2,659,478US$342.5m-0.89%0.03%
2.54%
State Street Global Advisors, Inc.
2,399,078US$308.9m20.8%0.01%
2.17%
BNY Mellon Asset Management
2,052,217US$264.3m-11.3%0.05%
1.59%
FMR LLC
1,506,976US$194.1m-21.2%0.01%
1.55%
Geode Capital Management, LLC
1,469,537US$189.2m4.31%0.02%
1.54%
Deutsche Asset & Wealth Management
1,454,358US$187.3m38.4%0.1%
1.42%
Citadel Advisors LLC
1,342,730US$172.9m9.35%0.18%
1.34%
Morgan Stanley, Investment Banking and Brokerage Investments
1,263,918US$162.8m74%0.02%
1.28%
Farallon Capital Management, L.L.C.
1,210,073US$155.8m-12%1.07%
1.2%
JP Morgan Asset Management
1,136,642US$146.4m-72.8%0.02%
1.16%
Pictet Asset Management Limited
1,091,602US$140.6m13.1%0.1%
1.11%
Dws Investment Gmbh
1,044,416US$134.5m0%0.09%
1.07%
Casdin Capital, LLC
1,006,500US$129.6m-0.38%11.29%
1.02%
Bank of America Corporation, Asset Management Arm
964,572US$124.2m1,160%0.06%
0.89%
Norges Bank Investment Management
836,849US$107.8m-3.11%0.01%
0.88%
EcoR1 Capital, LLC
832,907US$107.3m0%3.44%
0.88%
Thrivent Investment Management Inc.
828,708US$106.7m31.3%0.21%
0.85%
Camber Capital Management LP
800,000US$103.0m0%3.54%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.